Pfizer/BioNTech submit data to EMA for COVID-19 vaccine in young children

As India Awaits Covaxin for Children, Here's a Status Check of Vaccines for Those Below 18 Across Countries

Pfizer and BioNTech have asked US regulators to authorize emergency use of their COVID-19 vaccine for children ages 5 to 11.

Jarvis: Children must be vaccinated against nine diseases to go to school. Add COVID to the list.

Parents of young children will face a key decision when Health Canada approves Pfizer-BioNTech's COVID-19 vaccine for kids ages five to 11, possibly next month. Read More

Pfizer-BioNTech ask EU agency to OK vaccine for kids 5-11

Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union. If EU regulators agree, it would be the first opportunity for younger children in Europe to get immunized against COVID-19.

BioNTech : Pfizer and BioNTech Submit Data to EMA for the Vaccination of Children 5 to <12 Years of Age with COMIRNATY�

NEW YORK and MAINZ, Germany, October 15, 2021 - Pfizer Inc. and BioNTech SE today announced that they submitted data supporting the vaccination of children 5 to <12 years of age with... | October 15, 2021

The Latest: Pfizer seeks European OK for child vaccines

The Latest: Pfizer seeks European OK for child vaccines

Pfizer-BioNTech Seeks EU Agency's Approval To Vaccinate 5-To-11 Year Old Kids

Pfizer and BioNTech said they submitted data to the European Medicines Agency, including late-stage results from a study testing their COVID-19 vaccine in more than 2,200 children.